We tested the involvement of GRM3 in invasive responses by generating MMTV-PyMT tumour-derived cells in which GRM3 expression is disrupted by CRISPR gene editing (CRISPR-GRM3) (Supplementary Fig. 4a, b). The gene discussed is GRM3; the disease is neoplasm.